MISSISSAUGA, ON – B. Braun Canada Ltd. (B Braun) a leader in smart infusion therapy, safe and effective pharmacy products, patient and provider safety, and sustainable health solutions is pleased to announce the launch of Acetaminophen for Injection in the Ready-to-Use Mini-Plasco® and Ecoflac® plus containers and available in three sizes.

Acetaminophen Injection is a non-opioid analgesic and antipyretic indicated in adult and pediatric patients for the short-term management and treatment of¹: 

• mild to moderate pain
• moderate to severe pain with adjunctive opioid analgesics
• fever

Acetaminophen is a well-known analgesic and is often give in a tablet format. IV administration of Acetaminophen can provide a faster and more reliable approach to pain management when compared to oral or rectal administration^2,3. “B. Braun continues to lead the way with safe and effective solutions that add value to the Canadian healthcare system. Our Acetaminophen for Injection gives your staff the flexibility needed to provide the right dose to the right patient at the right time.” says Bob Comer, President of B. Braun Canada.  

Acetaminophen for injection is a key component of multimodal pain management. Canada is currently experiencing the effects of an opioid crisis that has claimed the lives of over 40,000 Canadians since 2016⁴. Mounting evidence supports the use of multimodal analgesia protocols that include IV acetaminophen for pain management that provide effective pain relief and decrease or eliminate the use of opioids and their associated complications⁵. Furthermore, other studies have demonstrated that reducing opioid use and including IV Acetaminophen for postoperative pain management has the potential to decrease opioid-related complication rates and costs from a hospital perspective⁶.

The Mini-Plasco and Ecoflac plus containers are brand new to the Canadian market. With great success in Europe for many decades, B. Braun Canada is excited to offer these innovative containers to Canadian clinicians. Both the Mini-Plasco and Ecoflac plus containers are not made with PVC, DEHP or natural rubber latex⁷. The Ecoflac plus containers are designed to prevent microbial ingress prior to spike⁸. They collapse as fluids are being administered. The Mini-Plasco container with an integrated finger stopper is designed for needle free access to the medication in the pharmacy. Both containers do not need an overwrap and are therefore designed to reduce plastic waste in hospitals. The 50 mL Ecoflac plus and 10 mL Mini-Plasco containers make up B. Braun’s pediatric offering for Acetaminophen Injection.

For more information on our portfolio of products that work together to help advance patient and clinician safety, visit www.bbraun.ca/ready-to-use-drugs.

About B. Braun 

B. Braun Canada Ltd. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we’re uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Mississauga, Ontario and is part of the B. Braun Group of Companies in North America which includes B. Braun Medical Inc., B. Braun Interventional Systems, Aesculap® and CAPS®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners, and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Canada, explore our website.

REFERENCES

1. Acetaminophen Injection (10 mg/ mL) Product Monograph, B. Braun of Canada, Ltd. Feb 24, 2023.
2. Howell TK & Patel D, Anesthesia 2003;58 (1): 69-73
3. Pettersson PH et al., Acta Anesthesiologica Scandinavica 2004;48: 867-70
4. Canada’s overdose crisis and the toxic illegal drug supply. Government of Canada Report. 2024.
5. Schwenk. E. S. & Mariano, E. R. Designing the ideal perioperative pain management plan stats with multimodal analgesia. Korean Journal of Anesthesiology. 2018. Vol 71. No. 5.
6. Shaffer E. E. et. al. Estimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs. 2016.
7. B. Braun Data on File.
8. Study Abstract. Evaluation of microbial barrier performance of Ecoflac plus infusion container during administration. March 2015.